KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Preferred Dividend Payments (2020 - 2023)

Boston Scientific (BSX) has disclosed Preferred Dividend Payments for 4 consecutive years, with $9.0 million as the latest value for Q2 2023.

  • Quarterly Preferred Dividend Payments fell 35.71% to $9.0 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Mar 2024, down 83.64% year-over-year, with the annual reading at $23.0 million for FY2023, 58.18% down from the prior year.
  • Preferred Dividend Payments hit $9.0 million in Q2 2023 for Boston Scientific, down from $14.0 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $14.0 million in Q3 2020 to a low of $5.0 million in Q2 2020.
  • Historically, Preferred Dividend Payments has averaged $12.8 million across 4 years, with a median of $14.0 million in 2020.
  • Biggest five-year swings in Preferred Dividend Payments: skyrocketed 180.0% in 2021 and later plummeted 35.71% in 2023.
  • Year by year, Preferred Dividend Payments stood at $14.0 million in 2020, then dropped by 7.14% to $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then plummeted by 30.77% to $9.0 million in 2023.
  • Business Quant data shows Preferred Dividend Payments for BSX at $9.0 million in Q2 2023, $14.0 million in Q1 2023, and $13.0 million in Q4 2022.